Comparing Glaxosmithkline & RIT Capital Partners

This page explains how Glaxosmithkline compares with RIT Capital Partners

In terms of market cap, Glaxosmithkline is 24.45 times greater than RIT Capital Partners, and each share in Glaxosmithkline is the equivalent to 0.87 shares in RIT Capital Partners.

  GSK   RCP
Price 1,733.50-266.502,000.00
Change 5.00 (0.29%)+0.79-10.00 (-0.5%)
Spread 0.50 (0.029%)-0.2215.00 (0.249%)
Currency GBX GBX
Sector Medicine and Biotech Closed End Investments
Indices UK All-Share, UK 350 , UK 100 UK All-Share, UK 250, UK 350
Glaxosmithkline Intraday Chart
RIT Capital Partners Intraday Chart
Glaxosmithkline 3 Month Chart
RIT Capital Partners 3 Month Chart
What if I invested £1,000?
1 month ago 1 year ago
GSK.LN/A N/A N/A N/A N/A
RCP.LN/A N/A N/A N/A N/A
  GSK   RCP
Shares in Issue 4,078,024,048   144,565,772
Market Capitalisation £70,692,546,872   £2,891,315,440
52 Week High 1,739.50   2,030.00
52 Week Low 1,302.60   1,698.00